Literature DB >> 1314844

Recovery of responses to ovine corticotropin-releasing hormone after withdrawal of a short course of glucocorticoid.

D F Brigell1, V S Fang, R L Rosenfield.   

Abstract

To characterize the recovery of the hypothalamic-pituitary-adrenal axis from suppression by short-term glucocorticoid treatment, we examined the responses to ovine CRH (oCRH) before and after prednisolone administration. Eight normal male volunteers were studied before (control) and after administration of 25 mg prednisolone twice daily orally for 14 days. Data are mean +/- SEM. The ACTH basal level was suppressed 24 h after prednisolone withdrawal (1.7 +/- 0.4 pmol/L vs. control, 3.5 +/- 0.6, P less than 0.02), but the ACTH response to oCRH was not significantly different from control (peak 12.8 +/- 2.0 pmol/L vs. 13.5 +/- 12.1, respectively). Seventy-two h post prednisolone basal ACTH levels had recovered to pretreatment values. Cortisol levels, both basal and in response to oCRH, were significantly suppressed 24 h post prednisolone (P less than 0.001). By 72 h post prednisolone, both basal and oCRH-stimulated cortisol had recovered to pretreatment levels. Dehydroepiandrosterone (DHEA), both basal and stimulated, was significantly suppressed 24 h post prednisolone (P less than 0.001). In contrast to cortisol, basal and peak DHEA remained suppressed 72 h post prednisolone (basal DHEA 9.1 +/- 1.1 nmol/L, P less than 0.05 vs. control; peak DHEA 20.0 +/- 3.3 nmol/L, P less than 0.01 vs. control). When expressed as percent rise, however, the DHEA response to oCRH was not significantly different from control. DHEA sulfate (DHEAS) was significantly lower than control at both 24 and 72 h post prednisolone (1.8 +/- 0.3 and 3.3 +/- 0.4 mumol/L respectively; control 7.2 +/- 0.7 mumol/L; P less than 0.001). The ratio of basal DHEA to DHEAS was significantly higher than control 72 h post prednisolone, indicating that DHEAS was more profoundly suppressed than DHEA. We conclude that after a short course of prednisolone pituitary ACTH secretion is the first parameter of the hypothalamic-pituitary-adrenal axis to recover. Hypothalamic secretion of CRH recovers next, followed by recovery of cortisol secretion. Secretion of DHEA and DHEAS remain suppressed after recovery of cortisol. This suppression may be caused by inhibition of sulfokinase activity by glucocorticoid.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1314844     DOI: 10.1210/jcem.74.5.1314844

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  The impact of peri-operative dexamethasone administration on the normal hypothalamic pituitary adrenal response to major surgical procedures.

Authors:  Katia El-Sibai; Aman Rajpal; Ribal Al-Aridi; Warren R Selman; Baha M Arafah
Journal:  Endocrine       Date:  2017-09-01       Impact factor: 3.633

2.  A comparison of pituitary-adrenal responses to corticotropin-releasing hormone, hypoglycaemia and metyrapone in children with brain tumours and growth hormone deficiency.

Authors:  I Fujiwara; Y Igarashi; E Ogawa
Journal:  Eur J Pediatr       Date:  1995-09       Impact factor: 3.183

3.  Therapeutic glucocorticoid administration alters the diurnal pattern of dehydroepiandrosterone.

Authors:  R Collomp; Z Labsy; H Zorgati; F Prieur; F Cottin; M C Do; O Gagey; F Lasne; K Collomp
Journal:  Endocrine       Date:  2013-12-18       Impact factor: 3.633

4.  Impact of short-term hydrocortisone intake on pituitary and adrenal function in healthy young male subjects.

Authors:  Katia Collomp; Virgile Amiot; Barbara Robin; Magnus Ericsson; Corinne Buisson
Journal:  Endocrine       Date:  2020-08-12       Impact factor: 3.633

Review 5.  Normal and Premature Adrenarche.

Authors:  Robert L Rosenfield
Journal:  Endocr Rev       Date:  2021-11-16       Impact factor: 19.871

6.  Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol.

Authors:  Conor P Woods; Nicola Argese; Matthew Chapman; Christopher Boot; Rachel Webster; Vijay Dabhi; Ashley B Grossman; Andrew A Toogood; Wiebke Arlt; Paul M Stewart; Rachel K Crowley; Jeremy W Tomlinson
Journal:  Eur J Endocrinol       Date:  2015-08-20       Impact factor: 6.664

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.